NVision Imaging Technologies
Leveraging quantum technology to enable imaging of cell metabolism via hyperpolarized MRI
Leveraging quantum technology to enable imaging of cell metabolism via hyperpolarized MRI
NVision Imaging Technologies is a biopharmaceutical startup founded in 2015 in Germany. The company's slogan, "Leveraging quantum technology to enable imaging of cell metabolism via hyperpolarized MRI," encapsulates its mission to engineer quantum-powered medical imaging technologies. NVision's innovative hyperpolarization device POLARIS facilitates fast, simple, and scalable imaging of metabolism at the cellular level, providing deeper and more precise MRI data. This breakthrough technology holds promising implications for various fields, including oncology, cardiology, and neurology. The company recently secured a noteworthy $30.00M Series A investment on 22 June 2023, attracting funding from notable investors such as Playground Global, Entrée Capital, Lauder Partners, Pathena, Sparkasse Ulm, b2venture (formerly btov Partners), and ES KAPITAL. NVision Imaging Technologies' pioneering approach to medical imaging positions it as a key player in the biopharmaceutical, biotechnology, and pharmaceutical industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $30.00M | 7 |
|
22 Jun 2023 |
| Grant | $2.70M | 1 | European Commission | 01 Apr 2023 |
| Grant | $4.90M | - | 12 Oct 2022 | |
| Grant | $1.70M | 1 | German Federal Ministry of Education and Research | 01 Jan 2022 |
| Grant | $1.00M | 1 | German Federal Ministry of Education and Research | 01 Jan 2022 |
No recent news or press coverage available for NVision Imaging Technologies.
We care about your data, and we'd love to use cookies make your experience better.
